Cargando...
Challenge to overcome: Nonstructural protein 5A-P32 deletion in direct-acting antiviral-based therapy for hepatitis C virus
Interferon (IFN)-based therapy for hepatitis C virus (HCV) infection has recently been replaced by IFN-free direct-acting antiviral (DAA)-based therapy, which has been established as a 1(st) line therapy with high efficacy and tolerability due to its reasonable safety profile. Resistance-associated...
Guardado en:
| Publicado en: | World J Gastroenterol |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Baishideng Publishing Group Inc
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6189846/ https://ncbi.nlm.nih.gov/pubmed/30344416 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v24.i38.4304 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|